The role of CPET for the assessment of patients with transthyretin amyloid cardiomyopathy

Back

HFA Premium Access

The role of CPET for the assessment of patients with transthyretin amyloid cardiomyopathy

Session: Phenotyping of amyloidosis

Topic: Exercise Testing

Speaker: Doctor D. Da Silva Correia (Lisbon, PT)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Debora Da Silva Correia

Hospital Santa Cruz, Lisbon (Portugal)

2 presentations

0 follower

6 more presentations in this session

Comparison of inferior vena cava wall thickness in patients with cardiac amyloidosis versus hypertrophic cardiomyopathy, a new diagnostic tool

Speaker: Doctor T. Li (Singapore, SG)

Automated detection of amyloid birefringence by digital pathology in endomyocardial biopsies

Speaker: Doctor A. Aimo (Pisa, IT)

Simple and specific prediction of the final diagnosis in patients with suspected amyloid cardiomyopathy and indication to tissue biopsy

Speaker: Doctor A. Aimo (Pisa, IT)

Clinical implications of cardiac implantable electronic devices in ATTR cardiomyopathy

Speaker: Doctor R. Saro (Trieste, IT) Doctor M. Merlo (Trieste, IT)

Evolving disease characteristics in cardiac amyloidosis: real-world data from a tertiary referral center

Speaker: Doctor P. Zwetsloot (Rotterdam, NL)

Access the full session

Phenotyping of amyloidosis

Speakers: Doctor D. Da Silva Correia, Doctor T. Li, Doctor A. Aimo, Doctor A. Aimo, Doctor R. Saro...

Access

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources